CLDN5 and myeloid sarcoma: This is in line with studies showing that downregulation of claudin-5 and occludin, mediated by upregulation of astrocyte-derived vascular endothelial growth factor (VEGF), significantly contributes to BBB breakdown in an animal model of MS [31].